Chengdu Olymvax Biopharmaceuticals Inc. Class ASSE: 688319

Preliminary Earnings Estimate for 2025

Feb 28, 2026 · Issued by Chengdu Olymvax Biopharmaceuticals Inc. Class A via Shanghai Stock Exchange

Preliminary Earnings Estimate for 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment